Historical record - last NADAC effective date: 3/22/2023
Product Information
FLUOXETINE HCL 40 MG CAPSULE is a generic product labeled by Vensun Pharmaceuticals, Inc., priced at $0.0736 per EA under NDC 42543072701. Its NADAC has been published 383 times since Dec 2, 2015.
FDA first approved this application on Mar 16, 2015. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/1
Manufacturer
Vensun Pharmaceuticals, Inc.NDC
42543072701
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
3/22/2023
Active Ingredients
FLUOXETINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204597FDA Approved
3/16/2015
TE Code
AB1
On Market Since
3/16/2015
Pharmacological Classes
Price Statistics
The NADAC for FLUOXETINE HCL 40 MG CAPSULE has been published 383 times since Dec 2, 2015, and over the history we have for it it has declined 52.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0736 per EA |
|---|---|
| All-time high | $0.1995 (May 11, 2016) |
| All-time low | $0.0653 (Jan 18, 2023) |
| Median price | $0.0926 |
| Average price | $0.1066 |
| Largest weekly change | -24.3% (Aug 21, 2019) |
| Weeks tracked | 383 |
| Tracking since | Dec 2, 2015 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
-0.8%
All
-52.9%
Last surveyed Mar 29, 2023 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 30% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Vensun Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Fluoxetine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin Reuptake Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FLUOXETINE HCL 40 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for FLUOXETINE HCL 40 MG CAPSULE, manufactured by Vensun Pharmaceuticals, Inc., is $0.0736 per EA (NDC 42543072701), effective Mar 29, 2023.
How has the price of FLUOXETINE HCL 40 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for FLUOXETINE HCL 40 MG CAPSULE has declined 52.9%. It has been tracked across 383 weekly CMS publications since Dec 2, 2015.
What are the highest and lowest recorded NADAC prices for FLUOXETINE HCL 40 MG CAPSULE?
Since Dec 2, 2015, the NADAC for FLUOXETINE HCL 40 MG CAPSULE has ranged from a low of $0.0653 (Jan 18, 2023) to a high of $0.1995 (May 11, 2016), with a median of $0.0926 per EA.
Are there cheaper alternatives to FLUOXETINE HCL 40 MG CAPSULE?
Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FLUOXETINE HCL 40 MG CAPSULE, is $0.0519 per EA — about 30% below FLUOXETINE HCL 40 MG CAPSULE.
Who manufactures FLUOXETINE HCL 40 MG CAPSULE?
FLUOXETINE HCL 40 MG CAPSULE (NDC 42543072701) is labeled by Vensun Pharmaceuticals, Inc., and CMS classifies it as a generic product.